Results out today confirm that the drug donanemab, hailed as a turning point in the fight against Alzheimer’s, slows cognitive decline by about a third.
The antibody treatment helps in the early stages of the disease.
It works in Alzheimer’s disease, not in other types of dementia, such as vascular dementia.
That is because it is designed to clear away one of the key features of Alzheimer’s disease – a substance called amyloid that builds up in the spaces between brain cells.
Please subscribe here: http://bit.ly/1rbfUog
#Dementia #Alzheimers #BBCNews
L'informazione della testata giornalistica di LA7 diretta da Enrico Mentana
After a California jury found Meta and YouTube liable in a landmark social media addiction case, we explain why the…
The golfer Tiger woods has been arrested and charged with driving under the influence after a high speed crash in…
A federal judge has temporarily blocked the Trump administration from making big changes to vaccines for children in the United…
Il costo del gasolio agricolo sale, ma gli aiuti più incisivi vanno altrove. Secondo Unimpresa, il settore agricolo rischia di…